GridAI Technologies

GRDXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$18.942 M

$2.74 -4.86%

Close of 7 Aug 2026

Revenue

$36.3K

#3636 by revenue

Earnings

-$6.39M

Loss-making

Shares outstanding

6,653,140

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#398CelularityCELU$20.3M
#399Werewolf TherapeuticsHOWL$19.3M
#400GridAI TechnologiesGRDX$18.9M
#401Rocket OneRKTO$18.9M
#402NeuroSense TherapeuticsNRSN$18.9M

Where these numbers come from

Share counts and financials for GridAI Technologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.